Table 2. Annual SeniorCare drug utilization and expenditures by drug type.
Year |
2014 |
2015 |
2016 |
2017 |
2018 |
|
|---|---|---|---|---|---|---|
All drugs | ||||||
Number of members (N) |
49,010 |
47,522 |
45,608 |
44,235 |
41,927 |
|
Number of 30-day drug fills |
2,295,818 |
2,196,129 |
2,096,209 |
2,008,878 |
1,916,660 |
|
Total expenditures ($) |
102,480,081 |
106,176,685 |
107,123,751 |
113,063,877 |
122,212,175 |
|
Source of payment (%) |
SeniorCare |
75.9 |
75.8 |
76.3 |
75.5 |
73.6 |
Member |
13.6 |
12.4 |
11.5 |
10.7 |
9.4 |
|
Other payers |
10.4 |
11.7 |
12.2 |
13.7 |
17.0 |
|
Average expenditures per 30-day drug fill ($) |
74 |
79 |
84 |
93 |
104* |
|
Average expenditures per member ($) |
2,091 |
2,234 |
2,349 |
2,556 |
2,915* |
|
Brand name drugs | ||||||
Number of members (N) |
30,672 |
28,366 |
24,805 |
23,193 |
21,339 |
|
Number of 30-day drug fills |
325,883 |
264,751 |
228,172 |
213,791 |
202,514 |
|
Total expenditures ($) |
79,692,847 |
81,152,030 |
84,491,081 |
89,291,934 |
99,678,772 |
|
Source of payment (%) |
SeniorCare |
80.7 |
80.2 |
80.7 |
79.4 |
76.6 |
Member |
7.7 |
6.7 |
5.8 |
5.2 |
4.4 |
|
Other payers |
11.6 |
13.1 |
13.5 |
15.4 |
19.0 |
|
Average expenditures per 30-day drug fill ($) |
295 |
357 |
417 |
465 |
532* |
|
|
Average expenditures per member ($) |
2,598 |
2,861 |
3,406 |
3,850 |
4,671* |
|
Generic drugs | ||||||
Number of members (N) |
48,431 |
46,925 |
45,013 |
43,643 |
41,405 |
|
Number of 30-day drug fills |
1,969,935 |
1,931,378 |
1,868,037 |
1,795,087 |
1,714,146 |
|
Total expenditures ($) |
22,787,234 |
25,024,655 |
22,632,670 |
23,771,942 |
22,533,403 |
|
Source of payment (%) |
SeniorCare |
59.2 |
61.6 |
59.9 |
61.1 |
60.6 |
Member |
34.4 |
31.2 |
32.9 |
31.6 |
31.6 |
|
Other payers |
6.4 |
7.2 |
7.2 |
7.3 |
7.8 |
|
|
Average expenditures per 30-day drug fill ($) |
20 |
22 |
21 |
23 |
24* |
|
|
Average expenditures per member ($) |
471 |
533 |
503 |
545 |
544* |
|
|
Specialty drugs | ||||||
Number of members (N) |
287 |
331 |
384 |
430 |
476 |
|
Number of 30-day drug fills |
1,657 |
1,892 |
2,211 |
2,400 |
2,884 |
|
Total expenditures ($) |
9,417,622 |
12,488,915 |
15,800,650 |
18,805,854 |
24,928,153 |
|
Source of payment (%) |
SeniorCare |
87.1 |
87.7 |
91.2 |
87.9 |
82.1 |
Member |
0.5 |
0.4 |
0.5 |
0.4 |
0.4 |
|
Other payers |
12.5 |
11.8 |
8.3 |
11.7 |
17.6 |
|
Average expenditures per 30-day drug fill ($) |
7,006 |
7,156 |
7,649 |
8,526 |
8,733* |
|
Average expenditures per member ($) |
32,814 |
37,731 |
41,148 |
43,735 |
52,370* |
|
Non-specialty drugs | ||||||
Number of members (N) |
49,004 |
47,510 |
45,601 |
44,222 |
41,908 |
|
Number of 30-day drug fills |
2,294,161 |
2,194,237 |
2,093,998 |
2,006,478 |
1,913,776 |
|
Total expenditures ($) |
93,062,459 |
93,687,770 |
91,323,101 |
94,258,023 |
97,284,022 |
|
Source of payment (%) |
SeniorCare |
74.8 |
74.2 |
73.8 |
73.1 |
71.5 |
Member |
15.0 |
14.0 |
13.4 |
12.8 |
11.7 |
|
Other payers |
10.2 |
11.7 |
12.8 |
14.1 |
16.8 |
|
|
Average expenditures per 30-day drug fill ($) |
66 |
70 |
71 |
77 |
84* |
|
|
Average expenditures per member ($) |
1,899 |
1,972 |
2,003 |
2,131 |
2,321* |
|
Source: Authors’ analysis of SeniorCare enrollment and drug claims data for the period January 2014– December 2018
Notes: Average expenditures per member were analyzed among the SeniorCare members who used each drug type.
Significant change compared to 2014, P<0.001